Stock ALM ALMIRALL, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Almirall, S.A.

Equities

ALM

ES0157097017

Pharmaceuticals

Real-time Estimate Tradegate
Other stock markets
 07:05:15 2024-04-18 am EDT 		5-day change 1st Jan Change
8.145 EUR +0.56% Intraday chart for Almirall, S.A. -1.27% -3.38%
Mar. 13 Almirall Signs License Deal with Eloxx Pharmaceuticals for Skin Diseases Treatment MT
Feb. 19 Global markets live: Apple, Nintendo, Super Micro Computer, Currys, ABB... Our Logo

Business Summary

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

Number of employees: 1,904

Sales per Business

EUR in Million2022Weight2023Weight Delta
Commercialization through Own Network
79.2 %
658 76.3 % 709 79.2 % +7.64%
Commercialization through Licensees
9.9 %
87 10.0 % 88 9.9 % +1.97%
Dermatology in the United States
6.4 %
74 8.6 % 57 6.4 % -22.50%
Corporate Management and Results Not Assigned to Other Segments
4.5 %
44 5.1 % 40 4.5 % -9.15%

Sales per region

EUR in Million2022Weight2023Weight Delta
Spain
33.2 %
274 31.7 % 297 33.2 % +8.42%
Germany
24.3 %
204 23.7 % 218 24.3 % +6.41%
Europe and the Middle East
14.4 %
95 11.1 % 129 14.4 % +34.82%
Italy
8.4 %
61 7.1 % 75 8.4 % +22.51%
United States
6.4 %
74 8.6 % 57 6.4 % -22.50%
America, Asia and Africa
5.4 %
52 6.0 % 49 5.4 % -6.61%
France
4.8 %
35 4.1 % 43 4.8 % +21.32%
United Kingdom
3.1 %
23 2.6 % 28 3.1 % +21.78%

Managers

Managers TitleAgeSince
Carlos Gallardo Piqué CEO
 Chief Executive Officer - 14-07-24
Michael McClellan DFI
 Director of Finance/CFO 54 19-11-10
Karl Ziegelbauer CTO
 Chief Tech/Sci/R&D Officer - 21-07-06
Volker Koscielny CTO
 Chief Tech/Sci/R&D Officer - 19-12-09
Eloi Crespo Cervera COO
 Chief Operating Officer - 96-12-31
Pablo Divasson del Fraile IRC
 Investor Relations Contact - -
Mercedes Diz SAM
 Sales & Marketing - 01-12-31
Isabel Gomes LAW
 General Counsel - 21-12-31
Paolo Cionini PRN
 Corporate Officer/Principal - -
Esteve Conesa Panicot HRO
 Human Resources Officer - 01-12-31

Members of the board

Members of the board TitleAgeSince
Thomas Fulton Wilson McKillop BRD
 Director/Board Member 81 07-05-28
Seth J. Orlow BRD
 Director/Board Member - 15-12-31
Eva-Lotta Allan BRD
 Director/Board Member 65 20-06-30
Enrique de Leyva Pérez BRD
 Director/Board Member 65 18-12-31
Karin Louise Dorrepaal BRD
 Director/Board Member 63 12-12-31
Carlos Gallardo Piqué CEO
 Chief Executive Officer - 14-07-24
Ruud Dobber BRD
 Director/Board Member - -
Alexandra Kimball BRD
 Director/Board Member - 20-06-30
Antonio Gallardo Torrededía BRD
 Director/Board Member - 13-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 209,393,724 72,826,288 ( 34.78 %) 0 34.78 %

Shareholders

NameEquities%Valuation
Grupo Corporativo Landon SL
60.14 %
125,935,455 60.14 % 1 124 M €
Norbel Inversiones SL
5.068 %
10,612,505 5.068 % 95 M €
Caixabank Asset Management SGIIC SA
1.443 %
3,022,056 1.443 % 27 M €
ALMIRALL, S.A.
1.285 %
2,690,101 1.285 % 24 M €
Oddo BHF Asset Management SAS
0.8672 %
1,815,927 0.8672 % 16 M €
Cobas Asset Management SGIIC SA
0.8201 %
1,717,231 0.8201 % 15 M €
Wellington Management International Ltd.
0.5417 %
1,134,187 0.5417 % 10 M €
Amundi Asset Management SA (Investment Management)
0.4572 %
957,414 0.4572 % 9 M €
Mutuactivos SA SGIIC
0.3181 %
666,117 0.3181 % 6 M €
Magallanes Value Investors SA SGIIC
0.2963 %
620,380 0.2963 % 6 M €

Holdings

NameEquities%Valuation
ALMIRALL, S.A.
1.28%
 2,690,101 1.28% 24,012,380 $

Company contact information

Almirall SA

Ronda General Mitre, 151

08022, Barcelona

+34 93 291 30 00

http://www.almirall.com
address Almirall, S.A.(ALM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Almirall, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
8.1 EUR
Average target price
11.28 EUR
Spread / Average Target
+39.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ALMIRALL, S.A. Stock Almirall, S.A.
-3.86% 1.8B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.79% 676B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.81% 554B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.64% 349B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.00% 318B
ABBVIE INC. Stock AbbVie Inc.
+5.99% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.47% 210B
NOVARTIS AG Stock Novartis AG
-0.02% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-9.98% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.71% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ALM Stock
  4. Company Almirall, S.A.